JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD Pharm. D V Year CLINICAL RESEARCH Previous Question Paper (October - 2020 - R08)

The pharmacological approach to drug discovery centers on identifying and validating biological targets to modulate disease processes. The process begins with target identification, where genomic, proteomic, or metabolomic studies reveal proteins or pathways involved in a disease. Once a target is identified, target validation confirms that modulating this target produces a therapeutic effect, often using gene knockout models or RNA interference.

Following validation, high-throughput screening (HTS) is employed to test large chemical libraries against the target to identify 'hits'. These hits are then refined into 'leads' through structure-activity relationship (SAR) studies, where chemical modifications are made to optimize potency, selectivity, and pharmacokinetic properties. The pharmacological profile is further refined through in vitro assays to determine efficacy and in vivo animal models to assess safety and therapeutic index before proceeding to clinical trials.

Drug characterization is the systematic process of determining the physical, chemical, and biological properties of a drug candidate to ensure its stability, purity, and efficacy. The process follows several key stages:

1. Physicochemical Characterization: Determination of molecular weight, solubility, partition coefficient (logP), pKa, and melting point. These properties dictate the drug's bioavailability and formulation potential.
2. Structural Elucidation: Utilization of analytical techniques such as Nuclear Magnetic Resonance (NMR) spectroscopy, Mass Spectrometry (MS), and Infrared (IR) spectroscopy to confirm the chemical structure and identity of the molecule.
3. Purity and Impurity Profiling: Use of High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) to quantify the drug substance and identify residual solvents, heavy metals, or degradation products.
4. Stability Testing: Assessment of the drug's shelf-life under various stress conditions (temperature, humidity, light) to determine degradation pathways and storage requirements.
5. Solid-State Characterization: Analysis of polymorphism, crystallinity, and particle size distribution using X-ray Powder Diffraction (XRPD) and Differential Scanning Calorimetry (DSC), which significantly influence dissolution rates and drug absorption.